1. Global and multi-national prevalence of fungal diseases—estimate precision;Bongomin;J. Fungi (Basel),2017
2. Invasive candidiasis;Pappas;Nat. Rev. Dis. Primers,2018
3. Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis;Socié;Br. J. Haematol.,2019
4. Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab;Jodele;Blood,2020
5. Federal-Drug-Administration. Eculizumab FDA label. https://www.accessdata.fda.gov/spl/data/68907414-19b7-43c7-be48-9768bb97d696/68907414-19b7-43c7-be48-9768bb97d696.xml#S5.1.